Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

Alibaba's Share Price Recovery Earns It Bullish Calls From Some Brokerages

Alibaba's Share Price Recovery Earns It Bullish Calls From Some Brokerages

Some of Wall Street's biggest brokerages have reiterated their bullish calls for Alibaba Group Holding Limited (NYSE: BABA), indicating more gains after it surged from a mid-March low,

Why Amazon Is Pushing DoorDash Stock Lower Today

Why Amazon Is Pushing DoorDash Stock Lower Today

DoorDash Inc (NYSE: DASH) shares are trading lower Wednesday after Amazon.com Inc (NASDAQ: AMZN) acquired a 2% stake in competitor company Grubhub.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Applied Molecular Shares Tumble After Disappointing Data From Mid-Stage Ulcerative Colitis Study

Applied Molecular Transport Inc (NASDAQ: AMTI) has

Meta Remains Adamant On NFT Push In Contrast With Google, Apple To Secure Its Metaverse Ambitions

Meta Platforms, Inc (NASDAQ:META) pushed ahead with plans to launch access to digital collectibles to its 3 billion users amid the crypto meltdown, the Financial Times reports. Meta would in no way adjust its plans around so-called non-fungible tokens, said new fintech head Stephane Kasriel in an interview with FT. The efforts are…

InflaRx's Stock Gains Following FDA Fast Track Status To Skin Disease Drug

The US Food and Drug Administration (FDA) granted a Fast Track designation to InflaRx’s (NASDAQ: IFRX) lead candidate Vilobelimab for the treatment of ulcerative Pyoderma Gangrenosum (PG).

Tesla's China Deliveries Climb To Record In June Amid Post-COVID Recovery: Report

U.S. electric vehicle giant Tesla, Inc. (NASDAQ: TSLA) reported record deliveries for June in China, as production ramped up following the COVID lockdowns.

inkl

Read news from The Economist, FT, and more,
with one subscription

EXCLUSIVE: Safe-T Sees Robust Revenue Growth Outlook of 175% For First Half 2022

EXCLUSIVE: Safe-T Sees Robust Revenue Growth Outlook of 175% For First Half 2022

Safe-T Group Ltd (NASDAQ: SFET), a global provider of cybersecurity and privacy solutions to consumers and enterprises, provided preliminary revenue guidance for the first half of fiscal 2022.

$10 Million Bet On This Stock? 3 Penny Stocks Insiders are Buying

$10 Million Bet On This Stock? 3 Penny Stocks Insiders are Buying

U.S. stock futures traded slightly lower this morning on Wednesday after the Nasdaq recorded sharp gains on Tuesday. Investors, meanwhile, focused on some notable insider trades.

Benzinga Before The Bell: FDA Temporarily Suspends Juul Ban, FTX Wants Bitcoin Derivatives, Voyager Digital Files For Chapter 11 Bankruptcy And Other Top Financial Stories Wednesday, July 6

Benzinga Before The Bell: FDA Temporarily Suspends Juul Ban, FTX Wants Bitcoin Derivatives, Voyager Digital Files For Chapter 11 Bankruptcy And Other Top Financial Stories Wednesday, July 6

CNBC Ben & Jerry’s Sues Parent Unilever On Israeli business Sale

Flora Growth Appoints Brandon Konigsberg To The Board Of Directors

Flora Growth Appoints Brandon Konigsberg To The Board Of Directors

At the annual meeting of shareholders of Flora Growth Corp. (NASDAQ: FLGC), held on July 5, 2022, the company’s shareholders voted in favor of all of the proposals submitted for their approval.

Kazia Shares Shoot Higher As FDA Grants Rare Pediatric Disease Designation To Brain Cancer Candidate

Kazia Shares Shoot Higher As FDA Grants Rare Pediatric Disease Designation To Brain Cancer Candidate

The United States Food and Drug Administration (FDA) has awarded Rare Pediatric Disease Designation (RPDD) to Kazia Therapeutics’ (NASDAQ: KZIA) lead drug Paxalisib for the treatment of atypical rhabdoid / teratoid tumors (AT/RT).

Highlights From Amazon-Just Eat Takeaway.com Collaboration

Highlights From Amazon-Just Eat Takeaway.com Collaboration

Amazon.com Inc (NASDAQ: AMZN) agreed to acquire a 2%

springbig Enters Into An Exclusive Partnership With Subscription-Based Service Kind+

springbig Enters Into An Exclusive Partnership With Subscription-Based Service Kind+

springbig (NASDAQ: SBIG) (NASDAQ: SBIGW), a leading provider of SaaS-based marketing solutions, consumer mobile app experiences, and omnichannel loyalty programs to the cannabis industry, entered into an exclusive partners

Get all your
news in one place.

100’s of premium titles.
One news app.

Why This Apple Analyst Sees iPhone Mix Shifting Toward High-End Models

As Apple, Inc. (NASDAQ: AAPL) gears up to launch its next iPhone iteration this fall, noted analyst Ming-Chi Kuo says the latest A16 processor would be exclusive to the two high-end iPhone Pro models.

H.B. Fuller And 2 Other Stocks Insiders Are Buying

Although the Nasdaq Composite jumped 1.75% on Tuesday, there were a few notable insider trades.

Cathie Wood's Ark Invest Sheds $35M In 3D Printing Company Stratasys — What It Bought Instead

As the market reopened following the long July 4 weekend, Cathie Wood-run Ark Invest made some portfolio moves, notable among which is the offloading of a huge chunk of Stratasys Ltd. (NASDAQ: SSYS) stake.

Key Takeaways From Amazon's Antitrust Case Settlement With EU Regulators; UK Watchdog Launches Similar Probe

Amazon.com Inc (NASDAQ: AMZN) has agreed to share more data with rivals and offer a wider choice of products for buyers under a deal with EU antitrust regulators,

Get all your
news in one place.

100’s of premium titles.
One news app.

Elon Musk Confesses To A 'Penchant' For This Piece Of Clothing

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk confessed his penchant for “creative socks” — something that sets him apart from Dogecoin (CRYPTO: DOGE) co-creator Billy Markus.<

Why Is SCWorx Jumping By Around 36%? 20 Stocks Moving In Wednesday's Pre-Market Session

Gainers Hexo Corp (NYSE: HEXO) rose 106.8% to $0.43 in pre-market trading. HEXO’s shareholders, on Tuesday, approved the note transaction with Tilray Brands.

From blockbuster to bust: Behind the precipitous drop in IPOs

Private companies are sitting on the sidelines in 2022 after a record setting year of initial public offerings fueled by cheap borrowing.

OpenBet Sports Betting Technology Powers Czech's Sazkabet Sportsbook

Light & Wonder Inc (NASDAQ:LNW) said its sports betting business, OpenBet, has delivered its full turnkey platform to Czech lottery company SAZKA a.s. and Czech-facing sportsbook brand, Sazkabet. Sazkabet selected OpenBet to power the next generation of its online and mobile sportsbook offering as part of a new agreement. Sazkabet has deployed the…

Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday

Gainers Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday.

Alert: This Malware Steals Your Crypto Via 'Free Bitcoin Mining' Links On YouTube

A new type of crypto-malware identified on Alphabet Inc-owned (NASDAQ: GOOG) (NASDAQ: GOOGL) Google's YouTube has been found to infect users' devices and steal from 30 different types of cryptocurrency wal

Markets Looking For Recession-Related Comments From Fed, Here's The Major Macro Issues For Wednesday

The Nasdaq 100 index settled higher on Tuesday, with shares of Tesla Inc (NASDAQ: TSLA) gaining around 2.5% despite JPMorgan lowering the price target on the stock from $395 to $385.

1 … 327 328 329 330

People

Christian Wiediger

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

electric vehicle

Ulcerative Colitis

Places

339,355 stories

131,053 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play